NCT03748134 2023-10-24Sintilimab or Placebo With Chemotherapy in Esophageal Squamous Cell Carcinoma ( ORIENT-15 )Innovent Biologics (Suzhou) Co. Ltd.Phase 3 Completed746 enrolled
NCT03116152 2021-02-03Study of IBI308 With Advanced/Metastatic Esophageal Squamous Cell Carcinoma After Failure of First-line TreatmentInnovent Biologics (Suzhou) Co. Ltd.Phase 2 Completed190 enrolled 14 charts